Moreover, the AMPK/mTOR signaling pathway should be taken into account when the affected enzymes are essential for the regulation of AMP levels (cN-I and cN-II loss-of-function variants and AMPD and ADK deficiency) or in HPRT deficiency. This evidence concerns the gene MTOR and hyperinsulinemic hypoglycemia, familial, 4.